Phase II study of liposomal vincristine (lipoV) in relapsed or refractory adult acute lymphoblastic leukemia (ALL).

被引:0
|
作者
Thomas, DA
Sarris, A
O'Brien, S
Cortes, J
Giles, FJ
Faderl, S
Keating, MJ
Burge, C
Cabanillas, F
Kantarjian, H
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[3] Inex Pharmaceut Corp, Burnaby, BC, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4269
引用
收藏
页码:238B / 238B
页数:1
相关论文
共 50 条
  • [31] A PHASE II STUDY WITH A SEQUENTIAL CLOFARABINE-CYCLOPHOSPHAMIDE COMBINATION SCHEDULE AS SALVAGE THERAPY FOR REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL) IN ADULT PATIENTS
    Bassan, R.
    Fumagalli, M.
    Meloni, G.
    Audisio, E.
    Cascavilla, N.
    Paolini, S.
    Specchia, G.
    Cerqui, E.
    Mico, C.
    Fabbiano, F.
    Ronco, F.
    Scattolin, A. M.
    Perfetti, P.
    Paoloni, F.
    Vitale, A.
    Vignetti, M.
    Foa, R.
    HAEMATOLOGICA, 2017, 102 : 199 - 199
  • [32] Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomibbased chemotherapy
    Zhao, Junmei
    Wang, Chao
    Song, Yongping
    Liu, Yuzhang
    Fang, Baijun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 211 - 214
  • [33] Results of a phase I study of clofarabine (CLO) plus cyclophosphamide (CY) in adult patients (pts) with relapsed and/or refractory acute lymphoblastic leukemia (ALL)
    Faderl, S.
    Thomas, D. A.
    Gandhi, V.
    Huang, X.
    Borthakur, G.
    O'Brien, S.
    Ravandi, F.
    Plunkett, W.
    Bretz, J. L.
    Kantarjian, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] A phase I trial of palbociclib in combination with dexamethasone in relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL).
    Kasner, Margaret T.
    Wilde, Lindsay
    Keiffer, Gina
    Palmisiano, Neil David
    Calabretta, Bruno
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia
    Camera, A
    Annino, L
    Chiurazzi, F
    Fazi, P
    Cascavilla, N
    Fabbiano, F
    Marmont, F
    Di Raimondo, F
    Recchia, A
    Vignetti, M
    Rotoli, B
    Mandelli, F
    HAEMATOLOGICA, 2004, 89 (02) : 145 - 153
  • [36] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
    Ottmann, O. G.
    Larson, R. A.
    Kantarjian, H. M.
    le Coutre, P. D.
    Baccarani, M.
    Hochhaus, A.
    Kim, D. W.
    Fan, X.
    Novick, S.
    Giles, F. J.
    LEUKEMIA, 2013, 27 (06) : 1411 - 1413
  • [37] A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
    Burke, Michael J.
    Lamba, Jatinder
    Weigel, Brenda
    Bachanova, Veronika
    Verneris, Michael R.
    Miller, Jeffrey S.
    BLOOD, 2012, 120 (21)
  • [38] A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
    Al-Kali, Aref
    Aldoss, Ibrahim
    Atherton, Pamela J.
    Strand, Carrie A.
    Shah, Bijal
    Webster, Jonathan
    Bhatnagar, Bhavana
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Buhrow, Sarah A.
    Kong, Jianping
    Reid, Joel M.
    Adjei, Alex A.
    Kaufmann, Scott H.
    CANCER MEDICINE, 2023, 12 (23): : 21229 - 21239
  • [39] Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory acute lymphoblastic leukemia in adults. A phase II study by the Polish Adult Leukemia Group (PALG)
    Giebel, S
    Krawczyk-Kulis, M
    Jakubas, B
    Adamczyk-Cioch, M
    Palynyczko, G
    Holowiecki, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 613S - 613S
  • [40] Phase I Study of Combination Chemotherapy Plus Ixazomib in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma (ALL)
    Atallah, Ehab
    Michaelis, Laura C.
    Carlson, Karen B.
    D'Souza, Anita
    Fenske, Timothy S.
    Pasquini, Marcelo C.
    Hamadani, Mehdi
    Baim, Arielle
    Guhl, Jessica
    Parameswaran, Hari
    BLOOD, 2016, 128 (22)